-
Apr 14/14 Apr 11/14 Dodd, David Alan Direct Ownership Common Shares 10 - Acquisition in the public market 87,000 $1.15 USD
Pipeline
http://www.aezsinc.com/en/page.php?p=20
New Presentation
http://www.aezsinc.com/pdfdyn/AEZS presentation June 2014.pdf
MACRILEN™(macimorelin)
•Filing of a New Drug Application ("NDA") seeking approval for the commercialization of MACRILEN™ as the firstavailable oral product indicated for the evaluation of Adult Growth Hormone Deficiency
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
Forum Rules